epalrestat
Epalrestat is a carboxylic acid derivative and a noncompetitive and reversible aldose reductase inhibitor used for the treatment of diabetic neuropathy, which is one of the most common long-term complications in patients with diabetes mellitus. Reference standards of Epalrestat API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Epalrestat (JP 0069)
[catalogue_number] => PA JP0069
[category_ids] => ,152,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => epalrestat-jp-0069-pajp0069
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA JP0069
Molecular Formula : NA
Molecular Weight : NA